PMID: 3323646Nov 2, 1987Paper

The influence of nutrition on the systemic availability of drugs. Part II: Drug metabolism and renal excretion

Klinische Wochenschrift
I Walter-Sack

Abstract

Plasma concentrations of an active compound vary between individuals and within a subject, even if the same drug dosage is used. These differences are related to variations of drug absorption from the gastrointestinal tract, of presystemic drug metabolism in the intestine or the liver, and of drug elimination from the systemic circulation, for instance by hepatic metabolism or renal excretion. All of these processes can be modified by nutrition. However it is necessary to emphasize the significance of the pharmaceutical formulation for variations of both drug absorption and elimination. The role of nutrition should receive adequate attention during therapeutic use of drugs as well as in drug disposition studies. Recent guidelines for the assessment of the systemic availability of drugs therefore do recommend nutrition to be controlled.

References

Nov 1, 1978·Clinical Pharmacokinetics·E M Sellers, M R Holloway
Sep 1, 1978·Clinical Pharmacokinetics·A Melander
Nov 1, 1977·Clinical Pharmacology and Therapeutics·A H ConneyA P Alvares
May 1, 1978·Clinical Pharmacokinetics·K Krishnaswamy
Jul 1, 1978·Clinical Pharmacokinetics·R I Ogilvie
Mar 1, 1979·Clinical Pharmacokinetics·P A Routledge, D G Shand
Aug 1, 1977·Clinical Pharmacology and Therapeutics·A P AlvaresA Kappas
Apr 1, 1979·British Journal of Clinical Pharmacology·J C MucklowM D Rawlins
Jul 1, 1979·Metabolism: Clinical and Experimental·B V HowardP H Bennett
Oct 1, 1979·Clinical Pharmacology and Therapeutics·T J MonksR L Smith
Oct 1, 1979·British Journal of Clinical Pharmacology·C BalabaudJ Paccalin
Apr 1, 1978·Clinical Pharmacology and Therapeutics·A KappasA H Conney
Sep 1, 1978·Clinical Pharmacology and Therapeutics·M FurlanutR Dainese
Jan 1, 1979·Clinical Pharmacology and Therapeutics·E J PantuckA H Conney
Jan 1, 1976·Clinical Pharmacokinetics·J R Bianchine, G M Shaw
Apr 1, 1977·British Journal of Clinical Pharmacology·J B Houston
Jul 1, 1977·Clinical Pharmacology and Therapeutics·A MelanderE Wåhlin
Jul 1, 1977·Clinical Pharmacology and Therapeutics·A MelanderE Wåhlin
Oct 1, 1977·Clinical Pharmacology and Therapeutics·J KapitulnikA H Conney
Nov 1, 1977·Clinical Pharmacology and Therapeutics·B N La Du
Nov 1, 1977·Clinical Pharmacology and Therapeutics·H S FraserC T Dollery
Dec 3, 1976·Science·E J PantuckA P Alvares
Dec 1, 1976·Clinical Pharmacology and Therapeutics·A H ConneyA Kappas
Dec 1, 1976·Clinical Pharmacology and Therapeutics·A KappasA P Alvares
Jul 1, 1976·Proceedings of the National Academy of Sciences of the United States of America·A P AlvaresA Kappas
May 1, 1975·Nature·J B Houston, G Levy
May 1, 1985·Clinical Pharmacokinetics·E A LaneM Linnoila
May 1, 1986·Clinical Pharmacokinetics·D R Abernethy, D J Greenblatt
Oct 1, 1986·Clinical Pharmacology and Therapeutics·P SmitsT Thien
Jun 1, 1987·Clinical Pharmacology and Therapeutics·G D ParkE Tsalikian
Aug 1, 1986·Clinical Pharmacology and Therapeutics·D JuanM C Frederiksen
Oct 1, 1986·Clinical Pharmacology and Therapeutics·L S OlanoffE C Conradi
Nov 1, 1986·Clinical Pharmacology and Therapeutics·J OnrotD Robertson
Nov 1, 1986·Clinical Pharmacology and Therapeutics·H W Overdiek, F W Merkus
Feb 1, 1987·British Journal of Clinical Pharmacology·V F ChallenorC F George
Apr 1, 1987·Clinical Pharmacology and Therapeutics·T C FaganT E Gaffney
Apr 1, 1985·Clinical Pharmacology and Therapeutics·C K SvenssonD Lalka
Mar 1, 1986·British Journal of Clinical Pharmacology·B G WoodcockN Rietbrock
Sep 26, 1985·The New England Journal of Medicine·W G BerlingerR Spector
Oct 1, 1985·Clinical Pharmacology and Therapeutics·A MelanderA McLean

❮ Previous
Next ❯

Citations

Jan 1, 1990·Pharmacology & Therapeutics·K F IlettR F Minchin
Dec 1, 1989·British Journal of Clinical Pharmacology·P A Winstanley, M L Orme
Oct 28, 2017·Drugs·Jianyuan DengTai Ning Lam

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Epigenetics Insights from Twin Studies

Find the latest research on epigenetics and twin studies here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Regulation of Vocal-Motor Plasticity

Dopaminergic projections to the basal ganglia and nucleus accumbens shape the learning and plasticity of motivated behaviors across species including the regulation of vocal-motor plasticity and performance in songbirds. Discover the latest research on the regulation of vocal-motor plasticity here.

Myocardial Stunning

Myocardial stunning is a mechanical dysfunction that persists after reperfusion of previously ischemic tissue in the absence of irreversible damage including myocardial necrosis. Here is the latest research.